Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

January 2033 14

  1. Study completion Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107971

  2. Study completion Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07232030

  3. Primary completion Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07232030

  4. Study completion A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359807

  5. Study completion LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07202897

  6. Study completion Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684742

February 2033 2

  1. Study completion Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07683923

  2. Primary completion Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07683923

March 2033 3

  1. Study completion Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835581

  2. Primary completion REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399692

  3. Primary completion REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399705

April 2033 2

  1. Study completion Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05484115

  2. Study completion Edwards EVOQUE Eos MISCEND Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02718001

May 2033 2

  1. Study completion Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613099

  2. Study completion Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07548281

June 2033 1

  1. Study completion Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07258290

July 2033 2

  1. Study completion ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07545512

  2. Primary completion ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07545512

August 2033 2

  1. Study completion Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07689279

  2. Primary completion Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07689279

September 2033 4

  1. Study completion Pre-emptive Coil Embolization in Endovascular Aortic Repair Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06975215

  2. Study completion PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05934487

  3. Study completion TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07334691

  4. Study completion A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05179876

October 2033 3

  1. Study completion Comparing the Safety and Efficacy of Apixaban and Rivaroxaban Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06953726

  2. Study completion The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06953778

  3. Primary completion Early Endovascular Repair Versus Surveillance for Women With Small Abdominal Aortic Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06394271

December 2033 6

  1. Study completion Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323581

  2. Study completion NORM-HF Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07574593

  3. Study completion Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07925502

  4. Study completion Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07928505

  5. Study completion LANDMARK Trial: a Randomised Controlled Trial of Myval THV Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04275726

  6. Study completion Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07794306

January 2034 2

  1. Study completion Evaluation of the GORE® Ascending Stent Graft Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05800743

  2. Study completion Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05051033

April 2034 1

  1. Study completion Early Endovascular Repair Versus Surveillance for Women With Small Abdominal Aortic Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06394271

June 2034 1

  1. Study completion Asian Diabetes Outcomes Prevention Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04286399

September 2034 5

  1. Study completion ACT-GLOBAL Adaptive Platform Trial for Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06352632

  2. Primary completion ACT-GLOBAL Adaptive Platform Trial for Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06352632

  3. Primary completion An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07923526

  4. Study completion Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07424690

December 2034 1

January 2035 2

  1. Study completion TRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07919366

  2. Primary completion Comprehensive Aneurysm Management Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04155606

February 2035 2

  1. Study completion RanDOmized stUdy Comparing Both Latest Generation Self-Expanding Valves and a Minimalist approaCH vs. Standard Of Care In transCathEter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05036018

  2. Study completion Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03560310

March 2035 2

  1. Study completion Harmony TPV Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05077774

  2. Primary completion ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06676280

April 2035 1

  1. Study completion Targeted Potassium Levels for Prevention of ICD Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03833089

August 2035 5

  1. Study completion Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01654133

  2. Primary completion Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01654133

  3. Study completion The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary Bifurcations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822322

  4. Study completion Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06814145

  5. Primary completion Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06814145

September 2035 2

  1. Study completion Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06353594

  2. Study completion The TRICURE US IDE Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07528326

December 2035 8

  1. Study completion MitraClip REPAIR MR Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04198870

  2. Study completion BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03646357

  3. Study completion Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03778554

  4. Study completion Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05454150

  5. Study completion PERIGON Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02088554

  6. Study completion ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06676280

  7. Study completion MEdical Treatment in Idiopathic Ventricular Fibrillation Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405229

  8. Study completion TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07798726

January 2036 2

  1. Study completion Comprehensive Aneurysm Management Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04155606

  2. Study completion Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211375

February 2036 1

  1. Study completion ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06608823

March 2036 1

  1. Study completion GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07166133

April 2036 2

  1. Study completion Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07478003

  2. Study completion ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05932615

June 2036 2

  1. Study completion GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06578741

July 2036 1

  1. Study completion Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03242642

September 2036 2

  1. Primary completion Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07627672

  2. Study completion Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07627672

November 2036 1

  1. Study completion Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06470022

December 2036 4

  1. Study completion Valvular Assessment of New Generation Aortic Replacement Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688448

  2. Study completion Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932314

  3. Primary completion Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932314

January 2037 2

  1. Study completion ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172960

  2. Study completion REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01252953

April 2037 1

  1. Study completion Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762560

June 2037 1

  1. Study completion PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04889872

September 2037 1

  1. Study completion Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414342

November 2037 1

  1. Primary completion To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116473

December 2037 3

  1. Study completion Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06122974

  2. Study completion To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116473

  3. Study completion Thrombolysis in Factor Xa-inhibitors Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06878066

March 2038 3

  1. Study completion ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06167213

  2. Study completion A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07194265

  3. Study completion ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07453407

April 2038 1

  1. Study completion PARTNER 3 Trial - Aortic Valve-in-Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03003299

September 2038 1

  1. Study completion Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687485

December 2038 2

  1. Study completion Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05496998

  2. Study completion Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07454980

January 2039 2

  1. Study completion REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399692

  2. Study completion REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399705

December 2039 1

  1. Study completion ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172973

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05711849

  2. Primary completion Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05711849

  3. Study completion Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05780359

  4. Study completion Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903170

  5. Primary completion A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06033950

  6. Primary completion Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06041594

  7. Study completion Etomidate Versus Propofol in CABG Surgery Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06068764

  8. Study start Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06122974

  9. Study completion Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06457685

  10. Study completion Telerehabilitation of Balance Clinical and Economic Decision Support System Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06534164

  11. Primary completion LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657326

  12. Primary completion Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06737757

  13. Primary completion CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06886113

  14. Primary completion Developing a Digital Aid to Improve ICD Decisions Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07084142

  15. Primary completion Stepped-Wedge Cluster Randomized Trial of AI-Assisted CTA Detection for Intracranial Aneurysms in Regional Hospitals Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07124624

  16. Primary completion Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07145463

  17. Primary completion ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07187713

  18. Study completion A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07229937

  19. Primary completion A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07229937

  20. Primary completion Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07281521

  21. Study completion Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374328

  22. Study start Intranasal Dexmedetomidine and Perioperative Myocardial Injury Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07549282

  23. Primary completion Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07581210

  24. Study start A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia Registry record

    Expected 2026-08; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07680829

  25. Study completion A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD) Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07716618

  26. Primary completion Combination of Novel Therapies for CKD Comorbid Depression Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04422652

  27. Study completion Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05565781

  28. Study completion Screening Using Portable Electronic Recorders for Sleep Apnea in Hypertensive At-Risk Populations (SUPER-SHARP Trial) Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05918120

  29. Primary completion Screening Using Portable Electronic Recorders for Sleep Apnea in Hypertensive At-Risk Populations (SUPER-SHARP Trial) Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05918120

  30. Primary completion Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922644

  31. Primary completion Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05930145

  32. Study completion Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis. Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05933720

  33. Primary completion The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06116357

  34. Study start Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339411

  35. Primary completion A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06717698

  36. Study start PRECISION-CPR: PRecision-Controlled Ventilation in CPR Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088120

  37. Study start Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485062

  38. Study start OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension) Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07576257

  39. Study start Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613970

  40. Study start Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07627672

  41. Study start A Study of Probiotics in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07651332

  42. Study start MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07685886

  43. Study start Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07715929

  44. Study start Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND) Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07717216

  45. Study start Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07744035

  46. Study start Non-Invasive Triage for Intracranial Hypertension in Prehospital Care Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07747636

  47. Study start Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07749014

  48. Study start Motor Cortex Stimulation for Post-Stroke Thalamic Pain Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07758829

  49. Study start Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766668

  50. Study start APEX-STROKE Adaptive Platform Trial for Stroke Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07784569

  51. Study start APEX-STROKE EAGLE Domain (EAGLE) Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07790354

  52. Study start The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent Registry record

    Expected 2026-09-01; that period ended on 2026-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818083

  53. Study start Sphere-9 PAF China Study Registry record

    Expected 2026-09-02; that period ended on 2026-09-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07789925

  54. Primary completion SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial Registry record

    Expected 2026-09-10; that period ended on 2026-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05831202

  55. Study start OPTImizing Lead Placement in Patients Requiring Pacemaker After Cardiac Surgery Registry record

    Expected 2026-09-10; that period ended on 2026-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795541

  56. Study completion Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia Registry record

    Expected 2026-09-11; that period ended on 2026-09-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05213104

  57. Study start ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves Registry record

    Expected 2026-09-12; that period ended on 2026-09-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07545369

  58. Study start A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery Registry record

    Expected 2026-09-14; that period ended on 2026-09-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07570940

  59. Study completion STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions Registry record

    Expected 2026-09-15; that period ended on 2026-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06734221

  60. Primary completion STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions Registry record

    Expected 2026-09-15; that period ended on 2026-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06734221

  61. Study start Augmenting Cerebral Blood Flow in Acute Ischemic Stroke Registry record

    Expected 2026-09-15; that period ended on 2026-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06911385

  62. Study start CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension Registry record

    Expected 2026-09-15; that period ended on 2026-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761572

  63. Study completion A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension Registry record

    Expected 2026-09-15; that period ended on 2026-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835971

  64. Study completion A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease Registry record

    Expected 2026-09-17; that period ended on 2026-09-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06717698

  65. Study completion iGlarLixi CGM Study in Chinese T2D Individuals After OADs Registry record

    Expected 2026-09-18; that period ended on 2026-09-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06671587

  66. Primary completion iGlarLixi CGM Study in Chinese T2D Individuals After OADs Registry record

    Expected 2026-09-18; that period ended on 2026-09-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06671587

  67. Study start Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE Registry record

    Expected 2026-09-21; that period ended on 2026-09-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870681

  68. Study completion Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) Registry record

    Expected 2026-09-22; that period ended on 2026-09-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04075981

  69. Study completion Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) Registry record

    Expected 2026-09-22; that period ended on 2026-09-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910476

  70. Primary completion Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) Registry record

    Expected 2026-09-22; that period ended on 2026-09-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910476

  71. Study start IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Registry record

    Expected 2026-09-28; that period ended on 2026-09-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07875179

  72. Primary completion Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease Registry record

    Expected 2026-09-29; that period ended on 2026-09-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06168994

  73. Study completion REDUCE LAP-HF TRIAL II Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03088033

  74. Primary completion Dabigatran for Mitral Stenosis Atrial Fibrillation Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045093

  75. Primary completion Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04111419

  76. Primary completion IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04221815

  77. Study completion Preeclampsia Postpartum Antihypertensive Treatment Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04298034

  78. Primary completion ASPIrin in Reducing Events in Dialysis ( ASPIRED ) Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04381143

  79. Study completion Multivessel TALENT Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04390672

  80. Study completion Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04479722

  81. Study completion Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04981184

  82. Primary completion Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04981184

  83. Study completion Morning Versus Bedtime Dosing of Antihypertensive Medication Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05089448

  84. Primary completion Empagliflozin in Hypertrophic Cardiomyopathy Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05182658

  85. Primary completion Serotonin Receptor Blockers in Ischemic Mitral Regurgitation Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05469165

  86. Study completion Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05544864

  87. Primary completion Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05544864

  88. Study completion Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06041594

  89. Study completion SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06047964

  90. Primary completion Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06052475

  91. Primary completion Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06144125

  92. Study completion Effects of Individualized iTBS on Upper Limb Function After Stroke Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06147167

  93. Study completion Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06270238

  94. Primary completion Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06270238

  95. Primary completion Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06297863

  96. Primary completion Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06353594

  97. Primary completion Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06512922

  98. Primary completion Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06520904

  99. Primary completion Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06524388

  100. Study start Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587737